Actually the company did send out information before the spike. Dean stated that approval was imminent, and "it's not if but when". He also stated that the FDA only had one question and it was related to labeling. We weren't aware of the new review team until well after the price settled back down to .70. I think we settled back down because approval didn't come quickly since Imaging3 only sent in the package responding to the labeling question.
The rise this past week I believe is due to the 150 day response expected by Sept. 8th. If that date passes without an FDA response, you'll see a drop in the following days and/or weeks. It's anyone's guess where it would settle, or if we get another rise this next week.
News 
Market Data 
Discover 
